Rakhmatov O. EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS. RAE [Internet]. 2023 May 30 [cited 2024 Nov. 21];2(5):269-78. Available from: https://researchedu.org/index.php/re/article/view/4001